Emitted dose estimates from Seretide® Diskus® and Symbicort® Turbuhaler® following inhalation by severe asthmatics
No === The dose emitted from dry powder inhalers may be inhalation flow-dependent. Using an ex vivo method, the Electronic Lung¿, we have measured the aerodynamic characteristics of the emitted dose for both active constituents from Seretide® Diskus® (salmeterol xinafoate 50 mcg; fluticasone propion...
Main Authors: | Assi, Khaled H., Chrystyn, Henry, Pearson, S.B., Tarsin, W. |
---|---|
Language: | en |
Published: |
2009
|
Subjects: | |
Online Access: | http://hdl.handle.net/10454/4128 |
Similar Items
-
Do Egyptian patients use their inhalers correctly? A checklist auditing for inhalation devices usage techniques
by: Ashraf Madkour, et al.
Published: (2015-04-01) -
Assessment of inhalation errors, training time and patient preference for DuoResp® Spiromax® and Symbicort® Turbuhaler® in patients with asthma and COPD
by: Jordi Giner, et al.
Published: (2020-01-01) -
Cost-effectiveness of budesonide Turbuhaler in the treatment of mild-to-moderate asthma in Japan
by: Terumasa Miyamoto, et al.
Published: (1999-01-01) -
The Clinical Evaluation of the Acceptance of Fluticasone Propionate Diskus® by Older Japanese Patients with Bronchial Asthma
by: Hiroyuki Ohbayashi
Published: (2005-01-01) -
High Performance Liquid Chromatography Assay Method for Simultaneous Quantitation of Formoterol and Budesonide in Symbicort Turbuhaler
by: Assi, Khaled H., et al.
Published: (2009)